Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) is a Healthcare company (Medical - Devices) with a market capitalization of $1.4B. The Maz Rating grades it against the other companies in its sector.
Lumexa Imaging Holdings, Inc. Common Stock's current Maz Rating and its five factor grades are for members: log in to see them.
At $14.63, Lumexa Imaging Holdings, Inc. Common Stock trades at 1.3x sales and 2.2x book value, with an EV/EBITDA of 21.1. Over the last twelve months it generated about $1.1B of revenue and a net loss of $25M. It runs a gross margin of 12.3%, an operating margin of 0.6% and a net margin of -1.6%. It shows return on equity of -2.8%, return on invested capital of 0.4% and a free cash flow yield of 3.9%. On the balance sheet: a debt-to-equity ratio of 1.54 and a current ratio of 1.52. Over the past 52 weeks the share price ranged from $6.45 to $19.45, with a beta of 0.99.
Lumexa Imaging Holdings, Inc. Common Stock does not currently pay a dividend.
2 Wall Street analyst ratings cover the stock: 1 Strong Buy and 1 Buy, for a Strong Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.